Phenylephrine Drugs Market Trends

• With a rise in respiratory illnesses like the common cold, allergies, sinusitis, and influenza, there's a corresponding increase in symptoms such as nasal congestion, sinus pressure, and runny nose. These discomforts drive individuals to seek relief, often turning to medications for symptomatic management that propels the growth of the market. For instance, as per the report published by Asthma and Allergy Foundation of America, in March 2023, more than 100 million people in the U.S. experience various types of allergies each year. Allergies are the sixth leading cause of chronic illness in the U.S. Each year in the U.S., it is estimated that anaphylaxis (a severe allergic reaction) to food results in 90,000 emergency room visits.
  
• Furthermore, the prevalence of these respiratory ailments leads to a greater preference for over the counter (OTC) drugs. Phenylephrine-based products, readily available without a prescription, capitalize on this trend, offering consumers quick access to relief.